Healthy Extracts Inc Stock Price, News & Analysis

Healthy Extracts Inc. (OTCQB: HYEX) announced the launch of its new product, Brain Activate - ENERGY Gel, a nootropic formulation for enhanced brain health and mental performance, now available on Amazon. This gel is designed to boost brain activation by 46% for up to eight hours and has no added sugars. The company aims to capitalize on Amazon's reach, anticipating strong sales and increased consumer awareness. The product is part of a broader marketing strategy, leveraging Whitney Johns as a brand influencer to attract further positive attention to Healthy Extracts' offerings.

Healthy Extracts (OTCQB: HYEX) has launched its new product, Brain Activate - ENERGY Gel™, a nootropic gel designed for mental energy and focus. This proprietary formulation, influenced by top brand influencer Whitney Johns, promises a 46% increase in brain activation for up to eight hours, devoid of added sugars and artificial sweeteners. The product features 90 MG of caffeine and utilizes Gelteq’s patented technology for enhanced absorption. The gel is positioned to compete with major energy drinks while supporting cognitive health. Whitney Johns' brand influence is expected to drive significant consumer reach.

Healthy Extracts Inc. (OTCQB: HYEX) reported a 32% increase in Q3 2022 net revenue, totaling $500,000, and a 40% rise in gross profit to $431,000, leading to a gross margin of 86.3%. Operating expenses decreased 30% to $486,000. Subscription customers surged 82% on Amazon and 54% for direct sales. For the first nine months, revenue rose 80% to $1.4 million, with net loss narrowing to $1.0 million. Management remains optimistic about future growth, emphasizing recent product launches and strategic retail partnerships.

Healthy Extracts Inc. (HYEX) has launched a new video series focusing on natural ways to enhance cardiovascular and sexual health using nitric oxide, known as the 'miracle molecule.' This initiative highlights the decline of nitric oxide production with age and its link to chronic diseases, particularly heart disease, which costs the U.S. approximately $363 billion annually. The series aims to educate viewers on increasing nitric oxide levels to improve health. The WHITNEY JOHNS ACTIVE™ supplement has been clinically proven to enhance nitric oxide levels by 73% and is available for purchase online.

Healthy Extracts Inc. (OTCQB: HYEX) has launched Whitney Johns' premium heart health supplement, Citrus Bergamot for Women, available exclusively on Amazon. This supplement is based on a formulation shown to improve heart health and support immune response, with 17 clinical studies backing its efficacy in reducing cholesterol. Featuring 18 ingredients tailored for women, it aims to enhance overall health. The heart health supplement market is projected to grow to $24.8 billion by 2027, providing a strong growth potential for Healthy Extracts and its innovative products.

Healthy Extracts Inc. (OTCQB: HYEX) reported a 93% increase in Q2 2022 net revenue, totaling $470,000, a record high. Subscription customers grew 51%, boosting subscription revenue by 52%. Despite a 31% increase in gross profit to $274,000, gross margin fell to 58% from 86% due to a one-time inventory write-down. The company expanded into retail with over 160 Natural Grocers stores and launched new products. The net loss was $859,000, up from $558,000 in the prior year. Cash increased to $159,000.

Healthy Extracts Inc. (OTCQB: HYEX) is launching its Citrus Bergamot SuperFruit™ heart health supplement, BergaMet PRO+™, on Fullscript.com. The launch will reach over 70,000 healthcare professionals and 5 million patients, expected to complete by Q3 2022. Supported by 17 clinical trials, Citrus Bergamot is known for improving heart health and cholesterol levels. Healthy Extracts holds the exclusive rights for Citrus Bergamot in the U.S. and Canada, with BergaMet PRO+ boasting a potent 47% BPF Gold. The heart-health supplement market is projected to grow significantly, indicating potential for growth.

Healthy Extracts Inc. (OTCQB: HYEX) has initiated a prospective trial to evaluate the impact of its UBN ACTIVATE™ supplement on golf performance. The study will assess energy conservation, mental focus, and overall scores among 10 golfers playing nine holes, both with and without the supplement. Conducted by the Colorado Center for Health and Sports Science, the trial aims to connect mental focus to scoring outcomes. Results are expected in October, with indications of positive preliminary feedback from users.